Parallel Advisors, LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 252 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$11,017
-44.8%
1,144
-39.1%
0.00%
-100.0%
Q2 2023$19,971
+12.7%
1,877
+11.4%
0.00%0.0%
Q1 2023$17,726
+36.6%
1,685
+60.9%
0.00%0.0%
Q4 2022$12,972
+44.1%
1,047
+15.2%
0.00%
Q3 2022$9,000
+12.5%
909
+23.5%
0.00%
Q2 2022$8,000
+700.0%
736
+1147.5%
0.00%
Q1 2022$1,00059
+168.2%
0.00%
Q3 2021$0
-100.0%
22
-79.6%
0.00%
Q2 2019$1,0001080.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
HealthInvest Partners AB 1,520,000$19,562,00018.54%
Sarissa Capital Management LP 16,390,000$210,939,00016.77%
Healthcare Value Capital, LLC 200,000$2,574,0005.13%
Camber Capital Management LP 7,500,000$96,525,0003.25%
13D Management LLC 650,455$8,371,0002.88%
BRIDGER MANAGEMENT, LLC 2,035,114$26,192,0002.44%
Brown Capital Management 18,484,759$237,899,0001.80%
Healthcare Value Capital, LLC 50,000$644,0001.28%
Zebra Capital Management LLC 53,359$687,0000.80%
PRICE MICHAEL F 520,000$6,692,0000.74%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders